Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

AMLODIPINE BESYLATE

FDA · NDA · 2026-05-08

AgencyFDA
Submission typeNDA
Action date2026-05-08
BrandSDAMLO
SponsorBRILLIAN PHARMA
RouteORAL

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-28T10:40:51.709Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: FDA:AMLODIPINE BESYLATE:2026-05-08

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

Same entity, elsewhere in the suite